PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials

2013-10-24
(Press-News.org) Contact information: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine
Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials SYDNEY, AUSTRALIA— Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases. One such strategy comes from a new abstract being presented October 28 at the 15th World Conference on Lung Cancer from researchers at Perelman School of Medicine at the University of Pennsylvania studying mesothelioma.

Results from a willingness to participate study, led by Charles B. Simone, MD, chief of Thoracic Oncology and assistant professor of Radiation Oncology at Penn's Abramson Cancer Center, found that focusing on particular factors—including hope for positive outcomes, randomization and altruism— and increasing the time spent with patients increased their likelihood of participating in a clinical trial for malignant pleural mesothelioma (MPM), a rare cancer often diagnosed in people who have been exposed to high levels of asbestos.

"Spending time with patients to thoroughly discuss the details, logistics, risks and benefits of enrollment can allow patients to have a better understanding of the proposed study, empower patients, and make them more likely to consider enrollment," said Dr. Simone. "Furthermore, identifying factors that may serve as obstacles to enrollment of a proposed study is critical and can help to tailor the discussion that researchers have with patients to address, substantiate, or alleviate their potential concerns."

The team, including Joseph S. Friedberg, MD, chief of the division of Thoracic Surgery and co-director of the Penn Mesothelioma and Pleural Disease Program, demonstrated unusually good results treating MPM with radical pleurectomy (RP), intraoperative photodynamic therapy (PDT), and chemotherapy. To establish if PDT is contributing to the results, a randomized trial of RP with and without PDT is needed. However, finding patients to enroll in such a trial is difficult.

To see if they could conduct the trial, the researchers conducted the willingness to participate study.

Patients with MPM who were candidates for RP plus PDT were enrolled. A total of 25 patients participated in structured interviews, reviewed a written description of a hypothetical randomized controlled trial comparing RP to RP plus PDT, answered open-ended and focused questions regarding their motivations for and concerns about enrollment, and completed a written questionnaire. Willingness to participate was assessed using a 6-point scale: 1=definitely not, 6=definitely.

Once factors were identified in eight patients, researchers trained physicians to spend more time talking about these factors with subsequent patients, and the length of time physician spent discussing the trial increased from 3 minutes to 9 minutes. Such factors included hope for positive outcomes, explaining the randomization process, physician's opinion, and altruism towards other patients. Focusing on such factors in the latter group resulted in a more willingness to participate: 71 percent of subsequent patients stated they would "definitely" or "probably" participate, as opposed to only 25 percent in the first group.

"Performing a willingness to participate study should be considered before a planned prospective clinical trial, especially for orphan diseases and rare conditions that are typically associated with poor clinical trial accrual," said Dr. Simone.

INFORMATION:

This study is one of 13 Penn Medicine studies and talks being presented at the International Association for the Study of Lung Cancer's 15th World Conference on Lung Cancer.

Co-authors of the study from Penn Medicine include Anand Shah, Melissa J. Culligan, Daniel Sterman, Evan Alley, Keith A. Cengel, and Stephen M. Hahn, and James P. Stevenson from the Cleveland Clinic.

END



ELSE PRESS RELEASES FROM THIS DATE:

USC researcher learns how to break a sweat

2013-10-24
USC researcher learns how to break a sweat Without sweat, we would overheat and die. In a recent paper in the journal PLOS ONE, USC faculty member Krzysztof Kobielak and a team of researchers explored the ultimate origin of this sticky, stinky ...

New device stores electricity on silicon chips

2013-10-23
New device stores electricity on silicon chips Solar cells that produce electricity 24/7, not just when the sun is shining. Mobile phones with built-in power cells that recharge in seconds and work for weeks between charges. These are just two ...

Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer

2013-10-23
Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer Nearly 80 percent of women who contacted a patient assistance program had some or all of their needs met, compared with ...

Advanced light source provides a new look at vanadium dioxide

2013-10-23
Advanced light source provides a new look at vanadium dioxide Graphene may command the lion's share of attention but it is not the only material generating buzz in the electronics world. Vanadium dioxide is one of the few known materials that acts ...

Gravitational waves 'know' how black holes grow

2013-10-23
Gravitational waves 'know' how black holes grow Supermassive black holes: every large galaxy's got one. But how did they grow so big? A paper in the journal Science pits the front-running ideas about the growth of supermassive black holes against observational data — a limit ...

There's gold in them thar trees

2013-10-23
There's gold in them thar trees Eucalyptus trees - or gum trees as they are know - are drawing up gold particles from the earth via their root system and depositing it their leaves and branches. Scientists from CSIRO made the discovery and have published their findings ...

The hitchhiker antigen: Cause for concern?

2013-10-23
The hitchhiker antigen: Cause for concern? Since antibodies first attained prominence as research reagents in modern biological science labs, researchers have been perplexed as to why one production lot can differ significantly from the next, ...

How are Open Access and MOOCS disrupting the academic community in different ways?

2013-10-23
How are Open Access and MOOCS disrupting the academic community in different ways? New article in SAGE Open compares and contrasts the disruptive tensions of open-access publishing with MOOCs Los Angeles, CA (October 23, 2013) Supporters of open academic content ...

New eye treatment effective in laboratory tests

2013-10-23
New eye treatment effective in laboratory tests Promising new approach may lead to treatments for common eye diseases like neovascular macular degeneration and diabetic retinopathy LA JOLLA, CA – October 23, 2013 – A promising technique for treating human eye disease ...

Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's

2013-10-23
Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's Mount Sinai researchers hope to exploit findings to develop novel preventive and treatment strategies for Alzheimer's disease New ...

LAST 30 PRESS RELEASES:

Attitudes, not income, drive energy savings at home

The playbook for perfect polaritons

‘Disease in a dish’ study of progressive MS finds critical role for unusual type of brain cell

Solar-powered method lights the way to a ‘de-fossilized’ chemical industry

Screen time linked to lower academic achievement among Ontario elementary students

One-year outcomes after traumatic brain injury and early extracranial surgery in the TRACK-TBI Study

Enduring outcomes of COVID-19 work absences on the US labor market

Affirmative action repeal and racial and ethnic diversity in us medical school admissions

Cancer progression illuminated by new multi-omics tool

Screen time and standardized academic achievement tests in elementary school

GLP-1RA order fills and out-of-pocket costs by race, ethnicity, and indication

Study finds HEPA purifiers alone may not be enough to reduce viral exposure in schools

UVA Health developing way to ID people at risk of dangerous lung scarring even before symptoms appear

How can we know when curing cancer causes myocarditis?

Male infertility in Indian men linked to lifestyle choices and hormonal imbalances

An acoustofluidic device for sample preparation and detection of small extracellular vesicles

The advent of nanotechnology has ushered in a transformative era for oncology, offering unprecedented capabilities for targeted drug delivery and controlled release. This paradigm shift enhances thera

A prototype LED as thin as wallpaper — that glows like the sun

Transnational electoral participation of undocumented Mexican immigrants in the US

A new method to build more energy-efficient memory devices for a sustainable data future

Freely levitating rotor spins out ultraprecise sensors for classical and quantum physics

‘Chinese lantern’ structure shifts into more than a dozen shapes for various applications

Towards light-controlled electronic components

Tiny architects, titanic climate impact: scientists call for October 10 to become International Coccolithophore Day

Stress sensitivity makes suicidal thoughts more extreme and persistent among the university population

Lessons from Ascension’s shark troubles could help boost conservation

Fire provides long-lasting benefits to bird populations in Sierra Nevada National Parks

Menstrual cycle affects women’s reaction time but not as much as being active

Housing associations more effective than government in supporting unemployed in deprived areas

Biochar helps composting go greener by cutting greenhouse gas emissions

[Press-News.org] Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials